BlackRock Japan’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
– Sell
-4,242
Closed -$13K – 1525
2016
Q2
$13K Buy
4,242
+420
+11% +$1.4K ﹤0.01% 1248
2016
Q1
$13K Buy
+3,822
New +$11.9K ﹤0.01% 1258
2015
Q4
– Sell
-2,746
Closed -$14K – 1467
2015
Q3
$14K Sell
2,746
-13,163
-83% -$75.4K ﹤0.01% 1139
2015
Q2
$102K Buy
15,909
+6,531
+70% +$43.7K ﹤0.01% 967
2015
Q1
$66K Hold
9,378
– – ﹤0.01% 1018
2014
Q4
$72K Sell
9,378
-4,972
-35% -$39.3K ﹤0.01% 1037
2014
Q3
$107K Buy
14,350
+856
+6% +$7.95K ﹤0.01% 941
2014
Q2
$131K Buy
13,494
+11,373
+536% +$101K ﹤0.01% 903
2014
Q1
$18K Sell
2,121
-31,283
-94% -$268K ﹤0.01% 1296
2013
Q4
$282K Sell
33,404
-23,006
-41% -$194K ﹤0.01% 843
2013
Q3
$450K Buy
56,410
+3,325
+6% +$26.7K ﹤0.01% 767
2013
Q2
$410K Buy
+53,085
New +$414K ﹤0.01% 757

Other funds holding PDLI

BlackRock Japan's PDLI Position: Q3 2016 in Review

BlackRock Japan sold out of PDL BioPharma, Inc. (PDLI) in Q3 2016, closing a stake of 4,242 shares — an estimated $13K sold.

BlackRock Japan first reported a position in PDLI in Q2 2013 and held it in 12 quarters. The position peaked at $450K in Q3 2013. 198 funds tracked by Wall St. Rank hold PDLI as of Q3 2016.

  • BlackRock Japan reported no remaining PDL BioPharma, Inc. position as of Q3 2016 after selling out during the quarter.
  • BlackRock Japan sold 4,242 PDL BioPharma, Inc. shares in Q3 2016, an estimated $13K.
  • BlackRock Japan first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 12 quarters.
  • BlackRock Japan's PDL BioPharma, Inc. position peaked at $450K in Q3 2013.
  • 198 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q3 2016.

Based on BlackRock Japan's 13F filing for Q3 2016, filed 8 Nov 2016.